Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

1994 • 747 citations

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

2000 • 695 citations

Combined modality therapy for primary CNS lymphoma.

1992 • 543 citations

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

2002 • 404 citations

Rituximab: Mechanism of action and resistance

2002 • 360 citations

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

2003 • 354 citations

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

2003 • 295 citations

Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.

2001 • 293 citations

Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.

2001 • 287 citations

Endothelial vesicles in the blood-brain barrier: are they related to permeability?

2000 • 136 citations

PCV salvage chemotherapy for recurrent primary CNS lymphoma

2000 • 104 citations

Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma

1994 • 101 citations

Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab.

2002 • 72 citations

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration

1998 • 71 citations

First-line therapy with temozolomide induces regression of primary CNS lymphoma

2002 • 41 citations

Chemotherapy With Dexamethasone, High-Dose Cytarabine, and Cisplatin for Parenchymal Brain Lymphoma

1988 • 32 citations

Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response.

2002 • 15 citations

Eosinophil networking under the microscope

2001 • 1 citations

Cited By (0)

Loading...